Group 1 - Company Leksin Medical closed at 13.8 yuan on May 27, with a decline of 1.36%, resulting in a rolling PE ratio of 42.48 times and a total market value of 3 billion yuan [1] - In the medical device industry, the average PE ratio is 49.11 times, with a median of 35.89 times, placing Leksin Medical at the 86th position [1] - On May 27, the net outflow of main funds for Leksin Medical was 4.541 million yuan, with a total outflow of 22.2631 million yuan over the past five days [1] Group 2 - Leksin Medical focuses on health IoT and digital health services, with main products including smart electronic blood pressure monitors, electronic health scales, smart blood glucose monitoring products, and ECG monitoring devices [2] - The company is recognized as a national high-tech enterprise and has established several engineering technology research centers, emphasizing the R&D, production, and sales of home medical health electronic products [2] - In the latest quarterly report for Q1 2025, Leksin Medical achieved an operating income of 273 million yuan, a year-on-year increase of 9.90%, and a net profit of 22.942 million yuan, a year-on-year increase of 67.88%, with a gross sales margin of 37.38% [2]
乐心医疗收盘下跌1.36%,滚动市盈率42.48倍,总市值30.01亿元